Christina U. Lorentz

1.0k total citations
36 papers, 728 citations indexed

About

Christina U. Lorentz is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Christina U. Lorentz has authored 36 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 19 papers in Genetics and 10 papers in Immunology. Recurrent topics in Christina U. Lorentz's work include Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Nerve injury and regeneration (5 papers). Christina U. Lorentz is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Nerve injury and regeneration (5 papers). Christina U. Lorentz collaborates with scholars based in United States, Canada and Ukraine. Christina U. Lorentz's co-authors include Owen J. T. McCarty, Erik I. Tucker, David Gailani, András Gruber, Beth A. Habecker, Monica T. Hinds, Joseph J. Shatzel, Cristina Puy, Michael Wallisch and Sven R. Olson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Christina U. Lorentz

34 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christina U. Lorentz United States	15	298	276	218	125	123	36	728
Michael Möllmann Germany	17	136 0.5×	142 0.5×	67 0.3×	187 1.5×	179 1.5×	66	875
Lakshmi Mundada United States	11	66 0.2×	133 0.5×	138 0.6×	202 1.6×	15 0.1×	14	541
Allan R. McPhaden United Kingdom	16	114 0.4×	57 0.2×	184 0.8×	135 1.1×	112 0.9×	53	712
Peter J. Spaeth Switzerland	14	97 0.3×	229 0.8×	26 0.1×	98 0.8×	297 2.4×	25	806
Karsten Schulze Germany	14	54 0.2×	71 0.3×	194 0.9×	150 1.2×	75 0.6×	24	556
Jacqueline Stone United States	9	106 0.4×	59 0.2×	85 0.4×	161 1.3×	27 0.2×	19	702
Hebe Agustina Mena Argentina	12	29 0.1×	96 0.3×	31 0.1×	131 1.0×	148 1.2×	18	515
Anne‐Marie Jank Germany	4	183 0.6×	162 0.6×	34 0.2×	265 2.1×	116 0.9×	4	835
Clementina Sitzia Italy	16	112 0.4×	11 0.0×	76 0.3×	395 3.2×	52 0.4×	26	641
Olivera Mitrović Ajtić Serbia	12	150 0.5×	112 0.4×	11 0.1×	216 1.7×	96 0.8×	60	571

Countries citing papers authored by Christina U. Lorentz

Since Specialization

Citations

This map shows the geographic impact of Christina U. Lorentz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina U. Lorentz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina U. Lorentz more than expected).

Fields of papers citing papers by Christina U. Lorentz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina U. Lorentz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina U. Lorentz. The network helps show where Christina U. Lorentz may publish in the future.

Co-authorship network of co-authors of Christina U. Lorentz

This figure shows the co-authorship network connecting the top 25 collaborators of Christina U. Lorentz. A scholar is included among the top collaborators of Christina U. Lorentz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina U. Lorentz. Christina U. Lorentz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Puy, Cristina, Jiaqing Pang, Christina U. Lorentz, et al.. (2024). Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo. Blood. 144(17). 1821–1833. 11 indexed citations

Puy, Cristina, Ravi S. Keshari, Robert Silasi‐Mansat, et al.. (2024). The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation. Journal of Biological Chemistry. 301(1). 108110–108110. 4 indexed citations

Kaempf, Andy, Jennifer M. Loftis, R. L. Woltjer, et al.. (2023). Role of platelet count in a murine stasis model of deep vein thrombosis. Platelets. 35(1). 2290916–2290916. 5 indexed citations

Fallon, Marie, Luke M. Healy, Christina U. Lorentz, et al.. (2023). OC 49.2 Pharmacological Targeting of the Contact Pathway Attenuates Experimental Autoimmune Encephalomyelitis in Mice. Research and Practice in Thrombosis and Haemostasis. 7. 100482–100482. 1 indexed citations

Cao, Yang, John H. Griffin, David Gailani, et al.. (2023). PB0592 Evaluation of the Role of Skeletal Muscle Myosin as a Cofactor for Factor XI Activation of Factor XII. Research and Practice in Thrombosis and Haemostasis. 7. 100789–100789. 1 indexed citations

Jordan, Kelley R., Cory Wyatt, Randy Woltjer, et al.. (2022). Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis. Journal of Thrombosis and Haemostasis. 20(9). 2035–2045. 14 indexed citations

Pfeffer, Michael, Jenny Wang, Christina U. Lorentz, et al.. (2022). Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial. Blood. 140(Supplement 1). 1247–1249. 1 indexed citations

Silasi‐Mansat, Robert, Ravi S. Keshari, Cristina Lupu, et al.. (2021). Factor XII plays a pathogenic role in organ failure and death in baboons challenged withStaphylococcus aureus. Blood. 138(2). 178–189. 19 indexed citations

Lorentz, Christina U., Erik I. Tucker, Norah G. Verbout, et al.. (2021). The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial. Blood. 138(22). 2173–2184. 89 indexed citations

10.

Ngo, Anh T. P., Kelley R. Jordan, Paul Müeller, et al.. (2021). Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient mice. Journal of Thrombosis and Haemostasis. 19(4). 1001–1017. 28 indexed citations

11.

Reitsma, Stéphanie E., Jiaqing Pang, Joseph J. Shatzel, et al.. (2021). Role of platelets in regulating activated coagulation factor XI activity. American Journal of Physiology-Cell Physiology. 320(3). C365–C374. 14 indexed citations

12.

Lorentz, Christina U., Jennifer Johnson, Cristina Puy, et al.. (2020). Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related Thrombosis. Cellular and Molecular Bioengineering. 14(2). 161–175. 15 indexed citations

13.

Tucker, Erik I., Norah G. Verbout, Brandon D. Markway, et al.. (2020). The protein C activator AB002 rapidly interrupts thrombus development in baboons. Blood. 135(9). 689–699. 7 indexed citations

14.

Wallisch, Michael, Christina U. Lorentz, Jennifer Johnson, et al.. (2020). Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primates. Research and Practice in Thrombosis and Haemostasis. 4(2). 205–216. 41 indexed citations

15.

Silasi‐Mansat, Robert, Ravi S. Keshari, Cristina Lupu, et al.. (2019). Inhibition of contact-mediated activation of factor XI protects baboons against S aureus–induced organ damage and death. Blood Advances. 3(4). 658–669. 57 indexed citations

16.

Wallisch, Michael, Erik I. Tucker, Christina U. Lorentz, et al.. (2017). The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation. Blood. 130. 236–236. 4 indexed citations

17.

Ghogha, Atefeh, et al.. (2015). BMP7‐induced dendritic growth in sympathetic neurons requires p75^NTR signaling. Developmental Neurobiology. 76(9). 1003–1013. 12 indexed citations

18.

Lorentz, Christina U., et al.. (2013). Sympathetic denervation of peri-infarct myocardium requires the p75 neurotrophin receptor. Experimental Neurology. 249. 111–119. 35 indexed citations

19.

Siao, Chia-Jen, Christina U. Lorentz, Pouneh Kermani, et al.. (2012). ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation. The Journal of Experimental Medicine. 209(12). 2291–2305. 68 indexed citations

20.

Habecker, Beth A., et al.. (2008). Regulation of cardiac innervation and function via the p75 neurotrophin receptor. Autonomic Neuroscience. 140(1-2). 40–48. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact